27.09.2023 - Conference Call Scheduled for October 3, 2023 at 11:00 am EASTERNDUBLIN, Sept. 27, 2023 (GLOBE NEWSWIRE) - Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical .
11.09.2023 - DUBLIN, Ireland, Sept. 11, 2023 (GLOBE NEWSWIRE) - Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that on .